BOESS CARSTEN 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Jun 20, 2024
Insider Transaction Report
Form 4
BOESS CARSTEN
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-13+23,944→ 23,944 totalExercise: $22.86Exp: 2034-06-13→ Common Stock (23,944 underlying)
Footnotes (1)
- [F1]. This option represents a right to purchase a total of 23,944 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2025.